MK4 vs MK7: Why Your Body Prefers One Form of K2

The label on your D3+K2 supplement says either MK4 or MK7. Search online, and most sources say MK7 is superior. But those sources are usually selling MK7 products.

The MK7 superiority argument rests on one metric: serum bioavailability. MK7 stays detectable in blood longer. But that metric misses where vitamin K2 ends up working inside your body, in bone, brain, and organ tissue.

I chose K2 as MK4 for Shine D3K2 because the research kept pointing in one direction. This article walks through what I found: the UBIAD1 conversion mechanism, tissue distribution data, and approximately 24 clinical trials that show why MK4 is the form the body prefers.

What Are MK4 and MK7?

MK4 and MK7 are both vitamin K2, but they're built differently and the body handles them in very different ways.

They belong to a family called menaquinones. MK4 has four isoprenoid units on its side chain. MK7 has seven. That structural gap changes everything about how each form gets absorbed and where it ends up.

Where They Come From

MK4 shows up in animal foods you probably already eat: egg yolks, butter, organ meats, dark chicken meat. Animals make it naturally in their tissues. MK7? Almost exclusively natto — fermented soybeans where bacteria produce it during fermentation. Some aged cheeses contain small amounts too.

Both show up on supplement labels. But here's the thing: whether one is "better" depends entirely on what you measure. Most MK4 vs MK7 comparisons focus on blood levels. That's only part of the story.

Why Does MK7 Show Higher Blood Levels Than MK4?

MK7 stays in the bloodstream longer because it binds to lipoproteins for slow transport, while MK4 is pulled into tissues within hours where it starts working.

The Study Behind the Narrative

The whole MK7-is-better narrative traces back to one small study. Ten women, ages 20-21. MK7 stayed detectable in blood for up to 48 hours. MK4? Undetectable at every single timepoint. That one trial launched an entire marketing narrative.

Why "Undetectable" Doesn't Mean "Inactive"

But there's a flaw in that interpretation. MK4's serum half-life is roughly two hours — and that rapid disappearance from blood isn't a weakness. It's the opposite. Your body pulls MK4 straight into the brain, bone, kidney, pancreas, and reproductive organs.

Here's a way to think about it. Judging K2 effectiveness by blood levels is like rating a delivery service by counting trucks still on the highway. What leaves the bloodstream fastest may be doing the most work. If a nutrient's invisible in a blood draw, it's often because it already reached where it needs to be.

Companies selling MK7 have a business interest in promoting serum bioavailability as the key metric. Brands like AlgaeCal and those using MenaQ7 promote MK7 because it's cheaper to produce at effective doses and offers a convenient once-daily dosing story.

Why Does the Body Convert All Vitamin K Into MK4?

The UBIAD1 enzyme converts every form of vitamin K, including K1, MK7, and MK9, into MK4, making it the form the body actively chooses.

The Discovery

A 2010 paper published in Nature revealed something striking. The human body contains a dedicated enzyme called UBIAD1. This enzyme converts phylloquinone (K1) and all menaquinones into MK4. The conversion happens inside the endoplasmic reticulum of cells.

A 2022 mouse study confirmed this further. Dietary K1, MK4, MK7, and MK9 all served as precursors to tissue MK4, supporting a universal conversion mechanism.

Why This Matters

UBIAD1 isn't scattered at random. It's concentrated in the brain, kidney, pancreas, bone, and reproductive tissues — the same places where MK4 piles up. Your body positioned this conversion machinery exactly where it needs the final product.

Ask yourself this. If MK7 were the preferred form, why would every major tissue run an enzyme that converts it into MK4? Biology doesn't waste energy on unnecessary conversions. The body turns other K forms into MK4 because that's what the tissues actually need.

Supplementing with MK4 provides the exact molecule the body already makes. Taking MK7 forces your system to do the conversion work first.

Factor	MK4	MK7
Serum half-life	~2 hours (rapid tissue uptake)	~68 hours (stays in blood)
Tissue accumulation	Brain, bone, kidney, pancreas, reproductive organs	Primarily liver
UBIAD1 conversion	Already the target form	Must be converted to MK4
Clinical bone trials	~24 trials, 8,882 participants in meta-analysis	4-7 trials
Fracture endpoint studies	Yes (Shiraki 2000, others)	0 studies
Brain K2 content	>98% of brain vitamin K	Trace amounts
Dosing frequency	1-3x daily (depending on dose)	Once daily

Which Form Has Stronger Clinical Evidence for Bones?

MK4 has approximately 24 clinical bone trials and a systematic review of 8,882 participants. MK7 has 4-7 bone trials and zero fracture endpoint studies.

The MK4 Record

The evidence gap between these two forms is hard to ignore. Researchers have studied MK4 in approximately 24 clinical trials for bone mineral density. A systematic review of 18 randomized controlled trials with 8,882 participants found consistent support for MK4's role in maintaining bone density at the hip and spine.

MK4 has also demonstrated fracture prevention. In a two-year trial, postmenopausal women taking 45mg of MK4 daily had a 10.9% fracture rate compared to 30.3% in the control group. That's roughly a 64% relative risk reduction. A larger trial (n=4,378) showed more modest results, but MK4 remains the only K2 form with fracture endpoint data.

Japan prescribes MK4 at 45mg/day as an approved treatment for osteoporosis under the brand name Glakay. No country has approved MK7 for osteoporosis treatment.

The MK7 Gap

Only 4-7 bone mineral density trials exist for MK7. Zero have measured fractures as an endpoint. The most cited MK7 bone study tracked postmenopausal women for three years and showed modest improvements in density markers, but never measured whether fewer bones actually broke.

Where MK7 Has an Edge

MK7 does carboxylate osteocalcin at lower doses. Once-daily dosing is convenient. But convenience doesn't translate to clinical superiority when the goal is preventing fractures.

How Does MK4 Support Brain Health?

MK4 makes up over 98% of all vitamin K in the brain and supports myelination, neuronal survival, and sphingolipid synthesis through the Gas6 and protein S pathways.

The Brain's Preference

The brain isn't subtle about which K2 it wants. More than 98% of the vitamin K in brain tissue is MK4. MK7? Barely detectable. The brain actively converts and stockpiles MK4 through the same UBIAD1 pathway.

What MK4 Does There

Two vitamin K-dependent proteins work continuously in the central nervous system: Gas6 and protein S. Gas6 supports cell survival, growth, and myelination. Myelination is the protective coating around nerve fibers that ensures fast, accurate signaling between neurons.

MK4 also plays a role in building sphingolipids, the lipids that form the structural backbone of brain cell membranes. Research links low vitamin K status to impaired cognition and elevated neuroinflammation.

The Dementia Connection

A community study found that higher brain MK4 concentrations were associated with 17-20% lower odds of dementia or mild cognitive impairment. This suggests MK4 levels in the brain matter for long-term cognitive health.

This connects to other nutritional challenges. Iron deficiency often brings brain fog and cognitive symptoms. For women dealing with both low iron and low vitamin D, supporting brain health through D3 + K2 as MK4 addresses multiple pathways at once.

Why Should D3 and K2 as MK4 Be Taken Together?

Vitamin D3 stimulates production of K-dependent proteins like osteocalcin and MGP, but these proteins need K2 to activate, making D3 alone incomplete without K2.

How the Synergy Works

D3 tells your cells to produce osteocalcin (for bones) and matrix Gla protein, or MGP (for arteries). But here's the catch — these proteins come out inactive. They sit there doing nothing until vitamin K2 flips the switch.

Without K2 to activate MGP, D3 on its own may actually push calcium into your arteries instead of your bones. Not ideal. Pairing D3 with K2 makes sure calcium goes to the skeleton, where you want it.

Clinical trials confirm this. In a multi-arm trial of postmenopausal women, only the combined D3+K2 group saw bone mineral density increase. D3 alone and K2 alone showed weaker effects.

The Iron Connection

This is where the MK4 vs MK7 debate connects to something most K2 articles never mention. Vitamin D and iron deficiency show up together more often than you'd expect. Vitamin D regulates hepcidin — that's the hormone controlling whether iron enters your bloodstream or stays locked away in storage. One JASN study found a single dose of vitamin D cut hepcidin by 34% in just 24 hours.

K2 backs up D3's work in the body. For women fighting iron deficiency, the D3 + K2 as MK4 combination supports the whole recovery picture — lower hepcidin opens the door for better iron absorption, which helps bring energy back. This matters especially for women managing iron deficiency during pregnancy, when iron needs spike.

Timing and Dosing

Take vitamin D in the morning with a fat source — it's fat-soluble, so it needs dietary fat to absorb well. Magnesium is an important co-factor too. Aim for vitamin D levels between 60 and 90 ng/mL. Shine D3K2 puts D3 + K2 as MK4 together in one capsule, so you don't have to juggle separate bottles.

Frequently Asked Questions About MK4 vs MK7

These are the most common questions about MK4, MK7, vitamin K2 supplementation, and how each form works in the body.

Is MK4 or MK7 better for bones?

MK4 has approximately 24 clinical bone trials, including studies with fracture endpoints. MK7 has 4-7 bone trials and zero fracture studies. The clinical evidence favors MK4.

At 45mg per day, MK4 reduced fracture rates by roughly 64% in one trial of postmenopausal women. MK7 has shown osteocalcin carboxylation but has never demonstrated fracture reduction in clinical trials.

Why does MK7 show higher blood levels than MK4?

MK7 has a longer serum half-life (around 68 hours vs about 2 hours for MK4) because MK4 is pulled into tissues like bone, brain, and kidney within hours.

Being undetectable in a blood test means MK4 has already been delivered to target tissues. Serum levels measure what's still circulating, not what the body has already put to work.

Can you take MK4 and MK7 together?

Totally safe. The body converts all vitamin K forms into MK4 through UBIAD1, so MK4 ends up being the active form no matter what.

Some supplements throw both in the bottle. It won't hurt you, but it's a bit redundant — your body's going to convert the MK7 into MK4 anyway. If you're picking one, the clinical evidence leans toward MK4.

Does vitamin K2 help with iron absorption?

K2 supports vitamin D3's function, and D3 has been shown to reduce hepcidin by 34%, which helps restore iron absorption in women with deficiency.

K2 doesn't work on iron directly. Instead, it supports D3's role in the body, and D3 is the one lowering hepcidin. For women with low iron, taking D3 + K2 as MK4 together supports the broader recovery picture alongside proper iron supplementation.

What is the best D3 and K2 ratio?

No universally agreed ratio exists, but higher D3 intake means your body produces more K-dependent proteins that need K2 to activate. The two should scale together.

Shine D3K2 pairs 5,000 IU of D3 with 500 mcg of K2 as MK4 — the exact form the body produces on its own. It was built for women who need both nutrients pulling in the same direction.

Conclusion

The MK4 vs MK7 debate comes down to one question: are you following marketing claims or biological evidence from clinical trials?

• MK4 is the endogenous form the body actively produces via UBIAD1. Supplementing with MK4 gives your cells the exact molecule they already make.
• Approximately 24 clinical trials support MK4 for bone density, compared to 4-7 trials and zero fracture studies for MK7.
• MK4 dominates brain tissue at over 98% of cerebral vitamin K, supporting neurological health through Gas6, protein S, and sphingolipid pathways.
• D3 + K2 as MK4 was the only combination that increased bone mineral density in a multi-arm trial, and D3's hepcidin-lowering effect supports iron absorption.

Check the label on your current D3+K2 supplement. If it lists MK7, consider switching to one that uses K2 as MK4, the form backed by clinical evidence and chosen by biology.

I built Shine D3K2 with K2 as MK4 because the evidence pointed in one direction. It delivers the same molecular form the body produces naturally and the most clinically studied form for bone health.